葡萄糖-6-磷酸脱氢酶缺乏症模拟非典型溶血性尿毒症综合征
一例4岁男孩表现为非免疫性溶血、血小板减少和急性肾损伤,初期诊断为补体介导的非典型溶血性尿毒症综合征(aHUS),经血浆置换和依库珠单抗治疗后肾功能改善,但后续两次出现溶血性贫血和血小板减少而无肾脏受累。全外显子测序发现G6PD致病性变异,功能分析证实红细胞G6PD活性降低,遂停用依库珠单抗。本病例提示G6PD缺乏症可模拟aHUS,建议将G6PD缺乏症纳入aHUS的鉴别诊断并检测红细胞G6PD浓度。
要点
- G6PD缺乏症可表现为与补体介导aHUS难以区分的临床表型。
- 对aHUS患者应检测红细胞G6PD活性以排除G6PD缺乏症。
- 依库珠单抗治疗无效时需考虑其他病因如G6PD缺乏症。
核心结论
- G6PD缺乏症可模拟补体介导的aHUS,建议将其纳入aHUS的鉴别诊断并测量红细胞G6PD浓度。
研究设计与样本
- 病例报告:一名4岁男孩,表现为非免疫性溶血、血小板减少和急性肾损伤。
主要发现
- 初期诊断为补体介导aHUS,予血浆置换和依库珠单抗治疗后肾功能快速改善。
- 依库珠单抗治疗期间尽管补体阻断充分,仍两次出现溶血性贫血和血小板减少,但无肾脏受累。
- 已知aHUS基因(CFH、CFI、CFB、C3、CD46、THBD、INF2和DGKE)未发现突变,抗H因子抗体未检出。
- 全外显子测序发现G6PD致病性变异,功能分析证实红细胞G6PD活性降低,遂停用依库珠单抗。
临床怎么用
- 对表现为aHUS的患者,应检测红细胞G6PD活性以鉴别G6PD缺乏症。
- 当aHUS患者对依库珠单抗治疗反应不佳或反复出现溶血时,需考虑G6PD缺乏症等替代诊断。
局限性
- 为单例病例报告,结论需在更大样本中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 4-year-old boy presented with nonimmune hemolysis, thrombocytopenia, and acute kidney injury. Investigations for an underlying cause failed to identify a definitive cause and a putative diagnosis of complement-mediated atypical hemolytic uremic syndrome (aHUS) was made. The patient was started initially on plasma exchange and subsequently eculizumab therapy, after which his kidney function rapidly improved. While on eculizumab therapy, despite adequate complement blockade, he presented 2 more times with hemolytic anemia and thrombocytopenia, but without renal involvement. Genetic analysis did not uncover a mutation in any known aHUS gene (CFH, CFI, CFB, C3, CD46, THBD, INF2, and DGKE) and anti-factor H antibodies were undetectable. Whole-exome sequencing was undertaken to identify a cause for the eculizumab resistance. This revealed a pathogenic variant in G6PD (glucose-6-phosphate dehydrogenase), which was confirmed by functional analysis demonstrating decreased erythrocyte G6PD activity. Eculizumab therapy was withdrawn. Complement-mediated aHUS is a diagnosis of exclusion and this case highlights the diagnostic difficulty that remains without an immediately available biomarker for confirmation. This case of G6PD deficiency presented with a phenotype clinically indistinguishable from complement-mediated aHUS. We recommend that G6PD deficiency be included in the differential diagnosis of patients presenting with aHUS and suggest measuring erythrocyte G6PD concentrations in these patients.
引用
- Walsh PR, Johnson S, Brocklebank V, et al. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome. Am J Kidney Dis. 2017. PMID: 29248304. doi:10.1053/j.ajkd.2017.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。